Document Detail

Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation.
MedLine Citation:
PMID:  18200579     Owner:  NLM     Status:  MEDLINE    
Patients with type 2 diabetes (T2DM) are known at risk for developing cardiovascular disease (CVD), nephropathy, and cancer. We were interested to find out whether multiple markers associated with chronic inflammation are detectable in patients with T2DM and are increased in patients with T2DM who developed additional clinical complications. A sequence of multiple risk markers for atherogenesis, associated with chronic inflammation, was measured in patients with T2DM before and after the development of clinical complications. We found that multiple clinical complications frequently developed simultaneously in patients with T2DM. At the early stage of T2DM, only low levels and low percent elevations of multiple risk markers were detected. However, both the level and the percent elevation of these markers were found to increase with disease progression and the development of clinical complications. We believe that chronic inflammation not only contributes to the pathogenesis of T2DM but also continues to increase in T2DM patients who are developing additional clinical complications. It appears that these multiple markers are potentially useful not only for monitoring the progression of T2DM but also predicting the risk of developing macro- and microvascular disease, nephropathy, and cancer.
Jawl-Shan Hwang; Tsu-Lan Wu; S C Chou; C Ho; Pi-Yueh Chang; Kuo-Chien Tsao; Jeng-Yi Huang; Chien-Feng Sun; James T Wu
Related Documents :
7097299 - Antibrain antibodies in multiple sclerosis. relation to clinical variables.
1769409 - Serological profiles as prognostic clues for progressive systemic scleroderma: the ital...
20498549 - Differential changes in deep and cortical gray matters of patients with multiple sclero...
8229049 - Mercury and selenium contents in amyotrophic lateral sclerosis in hokkaido, the norther...
7707089 - Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosi...
14967769 - Infratentorial lesions predict long-term disability in patients with initial findings s...
463759 - Intracardiac electrocardiography during permanent pacemaker implantation: predictors of...
6559049 - Partial deficiency of the fourth component of human complement (c4) and autoantibody di...
8317399 - Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical laboratory analysis     Volume:  22     ISSN:  0887-8013     ISO Abbreviation:  J. Clin. Lab. Anal.     Publication Date:  2008  
Date Detail:
Created Date:  2008-01-23     Completed Date:  2008-04-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8801384     Medline TA:  J Clin Lab Anal     Country:  United States    
Other Details:
Languages:  eng     Pagination:  6-13     Citation Subset:  IM    
Copyright Information:
(c) 2008 Wiley-Liss, Inc.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood*
Diabetes Mellitus, Type 2 / blood*,  complications*,  pathology
Diabetic Nephropathies / pathology
Disease Progression
Hemoglobin A, Glycosylated / metabolism
Inflammation / blood*,  complications*
Middle Aged
Reg. No./Substance:
0/Biological Markers; 0/Hemoglobin A, Glycosylated; 0/hemoglobin A1c protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical value of urinary kidney biomarkers for estimation of renal impairment in elderly Chinese wi...
Next Document:  Clinical and laboratory evaluation of idiopathic male infertility in a secondary referral center in ...